Logo image of ZTEK

ZENTEK LTD (ZTEK) Stock Fundamental Analysis

NASDAQ:ZTEK - Nasdaq - CA98942X1024 - Common Stock - Currency: USD

1.085  +0.01 (+1.4%)

After market: 1.05 -0.03 (-3.23%)

Fundamental Rating

2

Overall ZTEK gets a fundamental rating of 2 out of 10. We evaluated ZTEK against 187 industry peers in the Health Care Equipment & Supplies industry. ZTEK has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ZTEK is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ZTEK has reported negative net income.
In the past year ZTEK has reported a negative cash flow from operations.
In the past 5 years ZTEK always reported negative net income.
ZTEK had a negative operating cash flow in each of the past 5 years.
ZTEK Yearly Net Income VS EBIT VS OCF VS FCFZTEK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M

1.2 Ratios

ZTEK has a Return On Assets of -54.57%. This is in the lower half of the industry: ZTEK underperforms 68.98% of its industry peers.
Looking at the Return On Equity, with a value of -68.07%, ZTEK is in line with its industry, outperforming 42.78% of the companies in the same industry.
Industry RankSector Rank
ROA -54.57%
ROE -68.07%
ROIC N/A
ROA(3y)-49.9%
ROA(5y)-62.95%
ROE(3y)-57.84%
ROE(5y)-109.36%
ROIC(3y)N/A
ROIC(5y)N/A
ZTEK Yearly ROA, ROE, ROICZTEK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200 -250

1.3 Margins

With a Gross Margin value of 22.06%, ZTEK is not doing good in the industry: 78.61% of the companies in the same industry are doing better.
The Profit Margin and Operating Margin are not available for ZTEK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZTEK Yearly Profit, Operating, Gross MarginsZTEK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50K -100K -150K

More info and screens

3

2. Health

2.1 Basic Checks

ZTEK does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZTEK has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ZTEK has been increased compared to 5 years ago.
Compared to 1 year ago, ZTEK has an improved debt to assets ratio.
ZTEK Yearly Shares OutstandingZTEK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ZTEK Yearly Total Debt VS Total AssetsZTEK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

ZTEK has an Altman-Z score of 17.62. This indicates that ZTEK is financially healthy and has little risk of bankruptcy at the moment.
ZTEK has a better Altman-Z score (17.62) than 94.12% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that ZTEK is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.01, ZTEK is in the better half of the industry, outperforming 67.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 17.62
ROIC/WACCN/A
WACC7.83%
ZTEK Yearly LT Debt VS Equity VS FCFZTEK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.25 indicates that ZTEK should not have too much problems paying its short term obligations.
ZTEK has a worse Current ratio (1.25) than 81.28% of its industry peers.
A Quick Ratio of 1.00 indicates that ZTEK may have some problems paying its short term obligations.
The Quick ratio of ZTEK (1.00) is worse than 76.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 1
ZTEK Yearly Current Assets VS Current LiabilitesZTEK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

ZTEK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.11%, which is quite good.
ZTEK shows a strong growth in Revenue. In the last year, the Revenue has grown by 2827.85%.
The Revenue has been growing by 35.95% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)16.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.46%
Revenue 1Y (TTM)2827.85%
Revenue growth 3Y35.96%
Revenue growth 5YN/A
Sales Q2Q%13927.59%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZTEK Yearly Revenue VS EstimatesZTEK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 5M 10M
ZTEK Yearly EPS VS EstimatesZTEK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2023 2024 -0.05 -0.1 -0.15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ZTEK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZTEK Price Earnings VS Forward Price EarningsZTEK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZTEK Per share dataZTEK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ZTEK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZENTEK LTD

NASDAQ:ZTEK (7/11/2025, 8:00:02 PM)

After market: 1.05 -0.03 (-3.23%)

1.085

+0.01 (+1.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-02 2025-07-02/amc
Earnings (Next)08-12 2025-08-12
Inst Owners1.51%
Inst Owner Change0%
Ins Owners5.84%
Ins Owner ChangeN/A
Market Cap113.61M
Analysts84.44
Price TargetN/A
Short Float %0.03%
Short Ratio0.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 178.41
P/FCF N/A
P/OCF N/A
P/B 10.55
P/tB 10.55
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.01
BVpS0.1
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -54.57%
ROE -68.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.06%
FCFM N/A
ROA(3y)-49.9%
ROA(5y)-62.95%
ROE(3y)-57.84%
ROE(5y)-109.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30.75%
Cap/Sales 21.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 1
Altman-Z 17.62
F-Score4
WACC7.83%
ROIC/WACCN/A
Cap/Depr(3y)182.79%
Cap/Depr(5y)454.82%
Cap/Sales(3y)1708.52%
Cap/Sales(5y)12638%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2827.85%
Revenue growth 3Y35.96%
Revenue growth 5YN/A
Sales Q2Q%13927.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.97%
OCF growth 3YN/A
OCF growth 5YN/A